Charles Deignan
Finanzdirektor/CFO bei CLEARSIDE BIOMEDICAL, INC.
Vermögen: 425 183 $ am 30.04.2024
Profil
Charles A.
Deignan is currently the Chief Financial Officer at Clearside Biomedical, Inc. He previously worked as a Finance Manager at Schering-Plough Corp.
from 1990 to 1994, a Division Controller at AAIPharma, Inc., the President, Chief Financial Officer & Secretary at AtheroGenics, Inc. in 2009, and the Vice President-Finance & Administration at Salutria Pharmaceuticals, Inc. from 2009 to 2011.
Deignan received his undergraduate degree from Boston University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.04.2024 | 337 447 ( 0,45% ) | 425 183 $ | 30.04.2024 |
Aktive Positionen von Charles Deignan
| Unternehmen | Position | Beginn |
|---|---|---|
| CLEARSIDE BIOMEDICAL, INC. | Finanzdirektor/CFO | 01.01.2012 |
Ehemalige bekannte Positionen von Charles Deignan
| Unternehmen | Position | Ende |
|---|---|---|
Salutria Pharmaceuticals, Inc.
 Salutria Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Salutria Pharmaceuticals, Inc. operates drug stores. | Finanzdirektor/CFO | 01.12.2011 |
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | Präsident | 14.07.2009 |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Finanzdirektor/CFO | 01.01.1994 |
AAIPharma, Inc.
 AAIPharma, Inc. Miscellaneous Commercial ServicesCommercial Services AAIPharma, Inc. provides product development services to the pharmaceutical, biotechnology and medical device industries. Its services include drug delivery technologies, contract manufacturing, clinical packaging and distribution and bioanalytical services. The company was founded in 1979 and is headquartered in Wilmington, NC. | Corporate Officer/Principal | - |
Ausbildung von Charles Deignan
| Boston University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CLEARSIDE BIOMEDICAL, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | Health Technology |
AAIPharma, Inc.
AAIPharma, Inc. Miscellaneous Commercial ServicesCommercial Services AAIPharma, Inc. provides product development services to the pharmaceutical, biotechnology and medical device industries. Its services include drug delivery technologies, contract manufacturing, clinical packaging and distribution and bioanalytical services. The company was founded in 1979 and is headquartered in Wilmington, NC. | Commercial Services |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
Salutria Pharmaceuticals, Inc.
Salutria Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Salutria Pharmaceuticals, Inc. operates drug stores. | Retail Trade |
